It seems AstraZeneca just can’t catch a break this summer. After a tumultuous few months, the company reported a $3 million loss in the second quarter of 2016, from...
AstraZeneca was dealt a blow earlier this week when a judge denied a temporary restraining order that would have blocked the approval of generic versions of its blockbuster cholesterol...
The UK pharmaceutical giant, AstraZeneca, has had a rough few weeks both at home and abroad. The pharmaceutical and medical device industries are still reeling from the Brexit vote...
AstraZeneca has filed a lawsuit against the Food and Drug Administration (FDA) alleging new regulations would illegally broaden new uses for the generic versions its best selling cholesterol drug,...
